I-123 thyroid imaging

From RadsWiki

Jump to: navigation, search

Contents

[edit] Patient preparation

  • Discontinue any medications that interfere with thyroid uptake of rodioiodine.
  • NPO for 4 hours prior to study.

[edit] Radiopharmaceutical

I-123

Photon energy 159 keV
Adult dose Routine uptake and scan (100-400 microCi po); thyroid cancer scan (1.5 mCi po)
Peds dose
Physical half life 13.2 hours
Biological half life
Normal distribution Thyroid, nasopharynx, salivary glands, stomach, colon, bladder, lactating breasts
Pharmacokinetics Rapidly absorbed from GI tract; detectable activity within gland in minutes; reaches thyroid follicular lumen in 20-30 min; trapping and organification rapid; delayed imaging for background clearance; image at 6 and 24 hours; 10-30% uptake at 24 hours.
Excretion Renal
Target organ Thyroid, bladder, stomach, SI
Other Secreted in breast milk; crosses placenta; may cause cretinism; discontinue interfering medications

[edit] Dose and route of administration

100-400 microCi orally in capsule form

[edit] Time of imaging

At 4-6 or 24 hours

[edit] Equipment

  • Camera: Gamma camera
  • Collimator: 3- to 6-mm aperture pinhole collimator
  • Window: 20% energy window centered at 159 keV.

[edit] Procedure

  • Position the patient supine with the chin up and the neck extended.
  • Position the collimator so that the thyroid fills about two-thirds of the diameter of the field of view.
  • Obtain anterior, 45-degree LAO and RAO views (move the collimator, if possible, rather than the patient).
  • Obtain 100k-250k counts per view.
  • Mark the chin and suprasternal notch.
  • Note the position and mark palpable nodules and surgical scars.
  • Place marker sources lateral to the thyroid to calibrate size.

[edit] References